Both in Pharmaceuticals
Longeveron vs Alzamend Neuro
Over the past year LGVN returned −64.7% and ALZN returned −22.9%; their daily moves had a correlation of 0.06.
LGVN −64.7% ALZN −22.9%Growth of $1, one year, split-adjusted
| Metric | LGVN | ALZN |
|---|---|---|
| Price | $2.72 | $1.82 |
| Market cap | $8.7M | $8.8M |
| Today | +3.42% | +5.20% |
| 1 month | −59.5% | +9.6% |
| 6 months | −70.8% | +71.7% |
| Year to date | −46.2% | 0.0% |
| 1 year | −66.0% | −24.5% |
| Revenue growth (YoY) | −9.2% | — |
| Gross margin | 63.4% | — |
| Net margin | −2116.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.3× | — |
| Net cash | $10.1M | $7.6M |
| Dividend yield | — | — |
| Volatility (60d) | 706.7% | 49.7% |
| Short % of float | 0.8% | 3.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).